Literature DB >> 28319044

Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands.

Jooho Chung, Christen L Ebens, Eric Perkey, Vedran Radojcic, Ute Koch, Leonardo Scarpellino, Alexander Tong, Frederick Allen, Sherri Wood, Jiane Feng, Ann Friedman, David Granadier, Ivy T Tran, Qian Chai, Lucas Onder, Minhong Yan, Pavan Reddy, Bruce R Blazar, Alex Y Huang, Todd V Brennan, D Keith Bishop, Burkhard Ludewig, Christian W Siebel, Freddy Radtke, Sanjiv A Luther, Ivan Maillard.   

Abstract

Alloimmune T cell responses induce graft-versus-host disease (GVHD), a serious complication of allogeneic bone marrow transplantation (allo-BMT). Although Notch signaling mediated by Delta-like 1/4 (DLL1/4) Notch ligands has emerged as a major regulator of GVHD pathogenesis, little is known about the timing of essential Notch signals and the cellular source of Notch ligands after allo-BMT. Here, we have shown that critical DLL1/4-mediated Notch signals are delivered to donor T cells during a short 48-hour window after transplantation in a mouse allo-BMT model. Stromal, but not hematopoietic, cells were the essential source of Notch ligands during in vivo priming of alloreactive T cells. GVHD could be prevented by selective inactivation of Dll1 and Dll4 in subsets of fibroblastic stromal cells that were derived from chemokine Ccl19-expressing host cells, including fibroblastic reticular cells and follicular dendritic cells. However, neither T cell recruitment into secondary lymphoid organs nor initial T cell activation was affected by Dll1/4 loss. Thus, we have uncovered a pathogenic function for fibroblastic stromal cells in alloimmune reactivity that can be dissociated from their homeostatic functions. Our results reveal what we believe to be a previously unrecognized Notch-mediated immunopathogenic role for stromal cell niches in secondary lymphoid organs after allo-BMT and define a framework of early cellular and molecular interactions that regulate T cell alloimmunity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28319044      PMCID: PMC5373885          DOI: 10.1172/JCI89535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  Generation of new Notch2 mutant alleles.

Authors:  Brent McCright; Julie Lozier; Thomas Gridley
Journal:  Genesis       Date:  2006-01       Impact factor: 2.487

Review 2.  Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation.

Authors:  Cameron McDonald-Hyman; Laurence A Turka; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2015-03-25       Impact factor: 17.956

3.  Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

Authors:  Wei Zheng; Tuomas Tammela; Masahiro Yamamoto; Andrey Anisimov; Tanja Holopainen; Seppo Kaijalainen; Terhi Karpanen; Kaisa Lehti; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Blood       Date:  2011-05-12       Impact factor: 22.113

4.  Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.

Authors:  Kaifeng Lisa Lin; LeShara M Fulton; Matthew Berginski; Michelle L West; Nicholas A Taylor; Timothy P Moran; James M Coghill; Bruce R Blazar; James E Bear; Jonathan S Serody
Journal:  Blood       Date:  2014-01-10       Impact factor: 22.113

5.  The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development.

Authors:  Kyle Niessen; Gu Zhang; John Brady Ridgway; Hao Chen; Ganesh Kolumam; Christian W Siebel; Minhong Yan
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

6.  Coordinated regulation of lymph node vascular-stromal growth first by CD11c+ cells and then by T and B cells.

Authors:  Susan Chyou; Fairouz Benahmed; Jingfeng Chen; Varsha Kumar; Sha Tian; Martin Lipp; Theresa T Lu
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

Review 7.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

8.  Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.

Authors:  Motoko Koyama; Daigo Hashimoto; Kazutoshi Aoyama; Ken-ichi Matsuoka; Kennosuke Karube; Hiroaki Niiro; Mine Harada; Mitsune Tanimoto; Koichi Akashi; Takanori Teshima
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

9.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

Review 10.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

View more
  37 in total

Review 1.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Notch Signaling Orchestrates Helminth-Induced Type 2 Inflammation.

Authors:  Lauren M Webb; Elia D Tait Wojno
Journal:  Trends Immunol       Date:  2019-05-15       Impact factor: 16.687

3.  T cells take directions from supporting cast in graft-versus-host disease.

Authors:  Derk Amsen
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

4.  NOTCH SIGNALING IN CONTEXT: BASIC AND TRANSLATIONAL IMPLICATIONS.

Authors:  Jon C Aster
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

5.  Stem cell transplantation impairs dendritic cell trafficking and herpesvirus immunity.

Authors:  Carol A Wilke; Mathew M Chadwick; Paul R Chan; Bethany B Moore; Xiaofeng Zhou
Journal:  JCI Insight       Date:  2019-09-19

6.  Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.

Authors:  Vignesh Shanmugam; Jeffrey W Craig; Laura K Hilton; Matthew H Nguyen; Christopher K Rushton; Kian Fahimdanesh; Scott Lovitch; Ben Ferland; David W Scott; Jon C Aster
Journal:  Blood Adv       Date:  2021-01-12

7.  GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells.

Authors:  Eric Perkey; Dave Maurice De Sousa; Léolène Carrington; Jooho Chung; Alexander Dils; David Granadier; Ute Koch; Freddy Radtke; Burkhard Ludewig; Bruce R Blazar; Christian W Siebel; Todd V Brennan; Jeffrey Nolz; Nathalie Labrecque; Ivan Maillard
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

8.  An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

Authors:  Jonathan C Poe; Wei Jia; Hsuan Su; Sarah Anand; Jeremy J Rose; Prasanthi V Tata; Amy N Suthers; Corbin D Jones; Pei Fen Kuan; Benjamin G Vincent; Jonathan S Serody; Mitchell E Horwitz; Vincent T Ho; Steven Z Pavletic; Frances T Hakim; Kouros Owzar; Dadong Zhang; Bruce R Blazar; Christian W Siebel; Nelson J Chao; Ivan Maillard; Stefanie Sarantopoulos
Journal:  Blood       Date:  2017-08-29       Impact factor: 22.113

9.  Newly found arsons ignite the fire of gut GVHD.

Authors:  Defu Zeng
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

10.  One-two punch injury to tolerance mechanisms in graft-versus-host disease.

Authors:  Léolène J Carrington; Ivan Maillard
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.